Literature DB >> 20075004

Using difficulty resuming sleep to define nocturnal awakenings.

Maurice M Ohayon1, Andrew Krystal, Timothy A Roehrs, Thomas Roth, Michael V Vitiello.   

Abstract

OBJECTIVE: Nocturnal awakenings are one of the most prevalent sleep disturbances in the general population. Little is known, however, about the frequency of these episodes and how difficulty resuming sleep once awakened affects subjective sleep quality and quantity.
METHOD: This is a cross-sectional telephone study with a representative sample consisting of 8937 non-institutionalized individuals aged 18 or over living in Texas, New York and California. The interviews included questions on sleeping habits, health, sleep and mental disorders. Nocturnal awakenings were evaluated according to their frequency per week and per night, as well as their duration.
RESULTS: A total of 35.5% of the sample reported awakening at least three nights per week. Of this 35.5%, 43% (15.2% of the total sample) reported difficulty resuming sleep once awakened. More than 80% of subjects with insomnia symptoms (difficulty initiating or maintaining sleep or non-restorative sleep) also had nocturnal awakenings. Difficulty resuming sleep was associated with subjective shorter sleep duration, poorer sleep quality, greater daytime impairment, greater consultations for sleep disturbances and greater likelihood of receiving a sleep medication.
CONCLUSIONS: Nocturnal awakenings disrupt the sleep of about one-third of the general population. Using difficulty resuming sleep identifies individuals with significant daytime impairment who are most likely to seek medical help for their sleep disturbances. In the absence of other insomnia symptoms, nocturnal awakenings alone are unlikely to be associated with daytime impairments. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075004      PMCID: PMC2830306          DOI: 10.1016/j.sleep.2009.11.004

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  13 in total

Review 1.  Improving decisionmaking processes with the fuzzy logic approach in the epidemiology of sleep disorders.

Authors:  M M Ohayon
Journal:  J Psychosom Res       Date:  1999-10       Impact factor: 3.006

2.  Validation of expert systems: examples and considerations.

Authors:  M M Ohayon
Journal:  Medinfo       Date:  1995

3.  Validation of the sleep-EVAL system against clinical assessments of sleep disorders and polysomnographic data.

Authors:  M M Ohayon; C Guilleminault; J Zulley; L Palombini; H Raab
Journal:  Sleep       Date:  1999-11-01       Impact factor: 5.849

4.  Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers.

Authors:  G Lewis; A J Pelosi; R Araya; G Dunn
Journal:  Psychol Med       Date:  1992-05       Impact factor: 7.723

5.  Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication.

Authors:  Thomas Roth; Savina Jaeger; Robert Jin; Anupama Kalsekar; Paul E Stang; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2006-09-06       Impact factor: 13.382

6.  Insomnia in central Pennsylvania.

Authors:  E O Bixler; A N Vgontzas; H-M Lin; A Vela-Bueno; A Kales
Journal:  J Psychosom Res       Date:  2002-07       Impact factor: 3.006

7.  Epidemiology of insomnia: what we know and what we still need to learn.

Authors:  Maurice M Ohayon
Journal:  Sleep Med Rev       Date:  2002-04       Impact factor: 11.609

8.  Self-reported seasonality is associated with complaints of sleep problems and deficient sleep duration: the Hordaland Health Study.

Authors:  Nicolas M Øyane; Reidun Ursin; Ståle Pallesen; Fred Holsten; Bjørn Bjørvatn
Journal:  J Sleep Res       Date:  2008-03       Impact factor: 3.981

9.  Insomnia symptoms in a multiethnic sample of American women.

Authors:  Giardin Jean-Louis; Carol Magai; Georges J Casimir; Ferdinand Zizi; Frantz Moise; Dexter McKenzie; Yvonne Graham
Journal:  J Womens Health (Larchmt)       Date:  2008 Jan-Feb       Impact factor: 2.681

10.  Risk factors for insomnia in a rural population.

Authors:  Arthur J Hartz; Jeanette M Daly; Neal D Kohatsu; Ann M Stromquist; Gerald J Jogerst; Oladipo A Kukoyi
Journal:  Ann Epidemiol       Date:  2007-10-15       Impact factor: 3.797

View more
  16 in total

1.  Diagnostic and Statistical Manual criteria for insomnia related impairment in daytime functioning: polysomnographic correlates in older adults.

Authors:  Lara Kierlin; Richard Olmstead; Megumi Yokomizo; Perry Nicassio; Michael R Irwin
Journal:  Sleep Med       Date:  2012-06-19       Impact factor: 3.492

2.  Cataloging nocturia (circa 2014).

Authors:  Donald L Bliwise
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

3.  Hierarchy of insomnia criteria based on daytime consequences.

Authors:  Maurice M Ohayon; Dieter Riemann; Charles Morin; Charles F Reynolds
Journal:  Sleep Med       Date:  2011-10-28       Impact factor: 3.492

4.  The health-related quality-of-life impact of nocturnal awakenings in the middle-aged and older Finnish population.

Authors:  Saku Väätäinen; Henri Tuomilehto; Jouko Saramies; Jaakko Tuomilehto; Hannu Uusitalo; Esko Hussi; Sirkka Keinänen-Kiukaanniemi; Janne Martikainen
Journal:  Qual Life Res       Date:  2013-04-03       Impact factor: 4.147

5.  Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Authors:  Andrew D Krystal; Alan Lankford; H Heith Durrence; Elizabeth Ludington; Philip Jochelson; Roberta Rogowski; Thomas Roth
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

6.  Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.

Authors:  Annemiek Vermeeren; Eric F P M Vuurman; Tim R M Leufkens; Cees J Van Leeuwen; Anita C M Van Oers; Eugene Laska; Salvador Rico; Frank Steinberg; Thomas Roth
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

7.  Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.

Authors:  Thomas Roth; Andrew Krystal; Frank J Steinberg; Nikhilesh N Singh; Margaret Moline
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

8.  Prospective assessment of nocturnal awakenings in a case series of treatment-seeking chronic insomnia patients: a pilot study of subjective and objective causes.

Authors:  Barry Krakow; Edward Romero; Victor A Ulibarri; Shara Kikta
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

9.  Abnormally abrupt transitions from sleep-to-wake in Huntington's disease sheep (Ovis aries) are revealed by automated analysis of sleep/wake transition dynamics.

Authors:  William T Schneider; Szilvia Vas; Alister U Nicol; A Jennifer Morton
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

10.  A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adults.

Authors:  Amy Bullock; Handan Gunduz-Bruce; Gary K Zammit; Min Qin; Haihong Li; Abdul J Sankoh; Christopher Silber; Stephen J Kanes; Jeffrey Jonas; James Doherty
Journal:  Hum Psychopharmacol       Date:  2021-08-05       Impact factor: 2.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.